Trials / Unknown
UnknownNCT00375817
Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
A Phase II, Open-Label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of MyoCell Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bioheart, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and safety of MyoCell therapy on myocardial function in congestive heart failure patients, post-myocardial infarction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Myoblasts injection with MyoCath catheter |
Timeline
- Start date
- 2005-11-01
- Completion
- 2008-01-01
- First posted
- 2006-09-13
- Last updated
- 2007-10-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00375817. Inclusion in this directory is not an endorsement.